Oncological Impact and Benefit of Adjuvant Chemotherapy for Older Patients With Colon Cancer: A Multi‐Institutional Retrospective Study
Adjuvant chemotherapy provides significant survival benefits in older patients with high-risk stage III, but not high-risk stage II or low-risk stage III, colon cancer. Risk stratification, rather than age, should guide treatment decisions.
Authors
- I. Lee
- Jung Hoon Bae (ORCID: https://orcid.org/0000-0002-7598-2825)
- Ji Hoon Kim (ORCID: https://orcid.org/0000-0001-8510-4148)
- Yoon Suk Lee (ORCID: https://orcid.org/0000-0002-1492-367X)
- Jaeim Lee
- In Kyeong Kim
- Bong-Hyeon Kye
- Won Kyung Kang
- The Catholic Colorectal Group
Institutions
- The Catholic University of Korea St. Vincent's Hospital (KR)
- The Catholic University of Korea Incheon St. Mary's Hospital (KR)
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- ANZ Journal of Surgery
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1111/ans.70540
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00